CHARLES SCHWAB INVESTMENT MANAGEMENT INC

Position in PRAX — Praxis Precision Medicines, Inc.

CIK 884546 SAN FRANCISCO, CA

Position in PRAX

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$69,414,868

+$10,967,632 QoQ

Shares Held

215,447

+8.6% QoQ

Ownership

0.773%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2024

9 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $6,181,979,796 across 287 Biotechnology names. PRAX ranks #21 (1.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	1,920,871	$857,745,736
2	REGN	Regeneron Pharmaceuticals, Inc.	804,508	$621,595,061
3	MRNA	Moderna, Inc.	4,734,356	$240,505,284
4	ALNY	Alnylam Pharmaceuticals, Inc.	673,356	$222,793,299
5	INSM	INSMED Inc	1,069,390	$174,866,652
6	RVMD	Revolution Medicines, Inc.	1,735,476	$168,775,041
7	INCY	Incyte Corp	1,729,102	$162,743,080
8	BBIO	BridgeBio Pharma, Inc.	1,976,094	$146,744,740

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$69,414,868	215,447	+8.6%	Shares	Sole	2026-05-15
2025-12-31	$58,447,236	198,301	+22.7%	Shares	Sole	2026-02-13
2025-09-30	$8,568,033	161,661	+6.0%	Shares	Sole	2025-11-10
2025-06-30	$6,410,270	152,444	+8.1%	Shares	Sole	2025-08-12
2025-03-31	$5,342,699	141,080	-1.3%	Shares	Sole	2025-09-15
2024-12-31	$10,996,968	142,892	+4.3%	Shares	Sole	2025-02-06
2024-09-30	$7,885,972	137,052	+188.7%	Shares	Sole	2024-11-12
2024-06-30	$1,963,524	47,474	+609.7%	Shares	Sole	2024-08-12
2024-03-31	$408,162	6,689	—	Shares	Sole	2024-05-09
No filing history on record for this holder in this stock.